eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank

vol. 27

Intravenous immunoglobulin in clinical practice

Ewa Bernatowska
Janina Jastrzębska-Piotrowska
John Hooper

(Centr Eur J Immunol 2002; 27 (4): 169–175)
Online publish date: 2003/12/19


Although initially used for immunodeficiency disorders, intravenous immunoglobulin (IVIG) has been utilized as a prophylactic and therapeutic agent in a variety of other clinical conditions. The rapid growth in IVIG use is the result of improvements in IVIG preparations and reports of benefits in a number of unexpected clinical applications. IVIG has been used in such diverse diseases as primary immunodeficiencies, pediatric AIDS, low birth weight infants, bone marrow transplantation, chronic lymphocytic leukemia, idiopathic thrombocytopenic purpura, Kawasaki syndrome and demylinating polyneuropathies. However, important questions about doses and mechanisms still remain. This review describes clinical applications of IVIG that are clearly indicated and approved by national regulatory agencies. Other clinical applications supported by convincing clinical trials are also described.

intravenous immunoglobulin, immunoglobulin therapy

Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe